AbbVie Inc. (NYSE:ABBV) was a big mover last session, as the company saw its shares nearly 14% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company—as the stock is now up 26% in the past one-month time frame.
The move came after the company reported better-than-expected fourth-quarter 2017 results.
The company has seen no changes when it comes to estimate revision over the past few weeks, while the Zacks Consensus Estimate for the current quarter has also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
AbbVie currently has a Zacks Rank #2 (Buy) while its Earnings ESP is positive.
Investors interested in the Large Cap Pharmaceuticals industry may consider H. Lundbeck A/S (OTC:HLUYY) , which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Is ABBV going up? Or down? Predict to see what others think:Up or Down
Zacks Top 10 Stocks for 2018
In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-hold tickers for the entirety of 2018?
Last year's 2017 Zacks Top 10 Stocks portfolio produced double-digit winners, including FMC Corp (NYSE:FMC). and VMware which racked up stellar gains of +67.9% and +61%. Now a brand-new portfolio has been handpicked from over 4,000 companies covered by the Zacks Rank. Don’t miss your chance to get in on these long-term buys.
Access Zacks Top 10 Stocks for 2018 today >>
AbbVie Inc. (ABBV): Free Stock Analysis Report
H Lundbeck A/S (HLUYY): Free Stock Analysis Report
Original post